维普期刊资源整合服务平台（V6.5）

166篇 您的检索式：作者名="Kiyoi"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Prognostic Implication of FLT3 and N-RAS Gene Mutations in Acute Myeloid Leukemia 显示文摘	Hitoshi Kiyoi Tomoki Naoe Yasuyuki Nakano	1999	Blood1999，93，9：	1
2	Different antiapoptotie path- ways between wild - type and mutated FLT3 : insights into therapeu- tic targets in leukemia 显示文摘	Minami Y Yamamot o K Kiyoi H	2003	Blood2003，102，8：	1
3	New strategy for antedrug application : development of metalloproteinase inhibitors as antipsoriatic drugs显示文摘	SAWA M TSUKAMOTO T KIYOI T	2002	J Med Chem2002，45，4：	1
4	Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia显示文摘	KIYOI H HIROSE Y	2004	Blood2004，103，5：	1
5	New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation显示文摘	Kunio Kitamura Hitoshi Kiyoi Hitoshi Yoshida Tadasu Tobita Akihiro Takeshita Ryuzo Ohno Tomoki Naoe	1997	Cancer Chemotherapy and Pharmacology1997，，1：	1
6	New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs 显示文摘	Sawa M Tsukamoto T Kiyoi T	2002	J Med Chem2002，45，4：	1
7	New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs 显示文摘	Sawa M Tsukamoto T Kiyoi T	2002	J Med Chem2002，45，4：	1
8	Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin lelevels for disceiminating between hyperdestructive and hypoplastic thrombocytopenia显示文摘	Hayashi S Kiyoi T	2001	American Journal of Clinical Pathology2001，115，5：	1
9	Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia显示文摘	Ozcki K Kiyoi H Hirosc Y	2004	Blood2004，103，5：	1
10	Mechanisms of action and re- sistance to all-trans retinoic acid (ATRA) and arsenic trioxide(As203) in acute promyelocytic leukemia显示文摘	Tomita A Kiyoi H Naoe T	2013	Int J Hematol2013，97，6：	1
11	Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia 显示文摘	Kiyoi H Naoe T Nakano Y	1999	Blood1999，93，9：	1
12	Evaluation of edaravone a- gainst radiation-induced oral mucositis in mice显示文摘	Nakajima N Watanabe S Kiyoi T	2015	J Pharmacol Sci2015，127，3：	1
13	Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies显示文摘	YAMAMOTO Y KIYOI H NAKANO Y	2001	Blood2001，97，8：	1
14	Clinical significance of FLT3 in leukemia 显示文摘	Kiyoi H Yanada M Ozekia K	2005	Int J Hematol2005，82，2：	1
15	A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy:the Japan Adult Leukemia Study Group (JALSG) APL97 study显示文摘	Asou N Kishimoto Y Kiyoi H	2007	Blood2007，110，1：	1
16	Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines 显示文摘	Hayakawa F Towatari M Kiyoi H	2000	Oncogene2000，49，5：	1
17	New strategy for antedrug application:development of metalloproteinase inhibitors as antipsoriatic drugs显示文摘	Sawa M Tsukamoto T Kiyoi T	2002	J Med Chem2002，45，4：	1
18	New retinoids an arsenic compounds for the treatment of refractory acute promyelocytic leukemia:clinical and basic studies for the next generation显示文摘	KITAMURA K KIYOI H YOSHIDA H	1997	Cancer Chemother Pharmacol1997，，：	1
19	Different antiapoptotic pathways between wild-type and mutated FL T3 : insights into therapeutic targets in leukemia 显示文摘	Minami Y Yamamoto K Kiyoi H	2003	Blood2003，102，8：	1
20	Myeloid leukemia prognostic implication of FLT3 and N-ras gene mutations in acute leukemia显示文摘	Kiyoi H Naoe T Nakano Y	1999	Blood1999，93，9：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示